WASHINGTON DC (February 22, 2019) — US Senate Finance Committee Chairman Charles "Chuck" Grassley of Iowa and Ranking Member Ron Wyden of Oregon today began a bipartisan investigation into insulin prices. The probe is part of the committee’s broader effort to examine drug pricing in the United States and rising costs for consumers and taxpayers.